The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Hemedex sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Hemedex Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Hemedex is a medical device company that develops and manufactures tissue perfusion measuring devices. The company offers bowman perfusion monitors, which provides a minimally invasive technique to accurately and continuously measure perfusion in small volumes of tissue. It also provides perfusion probes, quantify tissue perfusion devices, titanium bolt single lumen bolt kits, titanium quad lumen bolt kits, titanium bolt dual lumen bolt kits, thermal infusion, BPM power cords, umbilical cords, perfusion measurement devices, probe fixation devices and replacement parts, among others. Hemedex’s services include critical care management, validation, clinical practice and research, multimodal monitoring, training, operation theory solutions, literature solutions, and research and development services. The company’s products are used in neurosurgery, reconstructive surgery, and organ transplantation clinical studies. Hemedex is headquartered in Cambridge, Massachusetts, the US.

The key metrics of Hemedex related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Hemedex is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Hemedex.

For a detailed understanding of the performance of Hemedex, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.